Context Therapeutics Inc

NASDAQ:CNTX  
2.10
+0.13 (+6.60%)
Other Pre-Announcement

Context Therapeutics Reports Third Quarter 2021 Operating And Financial Results

Published: 12/02/2021 21:13 GMT
Context Therapeutics Inc (CNTX) - Context Therapeutics® Reports Third Quarter 2021 Operating and Financial Results.
Context Therapeutics - Expects Cash & Cash Equivalents Will Be Sufficient to Fund Its Operations Into 2024.
Context Therapeutics - Qtrly Loss per Share $4.00).